About KEIFERX LLC
KeifeRx is a clinical-stage biopharma company focused on developing kinase inhibitors to treat neurodegenerative diseases such as Alzheimer's, Parkinson's, and dementia by targeting the root causes of these conditions.
Development of kinase inhibitors for neurodegenerative diseasesRestoration of autophagy to remove toxic protein buildupTargeting microglial-mediated neuroinflammation and vascular damageDesign of drug candidates with superior brain penetration and potency
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KEIFERX LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.